Silexion Therapeutics Announces 1-for-10 Reverse Share Split
On May 29, 2026, trading for Silexion will commence on a split-adjusted basis at the market open. This strategic adjustment aims to assist Silexion in meeting Nasdaq requirements and bolstering its market standing. The move will support the company's advancement in developing SIL204, showcasing its commitment to growth and compliance.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments